Clinical Trial Detail

NCT ID NCT02605486
Title Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

breast cancer

Therapies

Bicalutamide + Palbociclib

Age Groups: adult senior

Additional content available in CKB BOOST